| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |